Related Experiment Videos
Elimination of clonogenic leukemic cells from bone marrow using monoclonal antibodies and magnetic immunobeads
S Murakami1, C Shimazaki, N Oku
1Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chromosome 14 Abnormality with a Breakpoint of p12 in Adult T-cell Leukemia.
Leukemia & lymphoma·2016
Modified ELISPOT assay may predict T-cell hyporesponsiveness to non-inherited maternal antigens.
International journal of laboratory hematology·2008
The effects of thalidomide on chemotactic migration of multiple myeloma cell lines.
International journal of laboratory hematology·2008
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
Eculizumab in rapidly progressive glomerulonephritis: a case-series report.
Frontiers in immunology·2026
Flurbiprofen for Inflammatory Bowel Disease: A Review of Colon-Targeted Formulations.
Recent advances in drug delivery and formulation·2026
Heart-specific T cell responses: from antigens to disease mechanisms.
Nature reviews. Cardiology·2026
Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials.
Critical reviews in oncology/hematology·2026